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Background: The quantiﬁcation of total (free + sulfated) metanephrines in urine is recommended to diagnose pheochromocytoma. Urinary metanephrines 
include metanephrine itself, normetanephrine and methoxytyra-mine, mainly in the form of sulfate conjugates (60–80%). Their determination requires the 
hydrolysis of the sul-fate ester moiety to allow electrochemical oxidation of the phenolic group. Commercially available urine calibrators and controls contain 
essentially free, unhydrolysable metanephrines which are not representative of native urines. The lack of appropriate calibrators may lead to uncertainty 
regarding the completion of the hy-drolysis of sulfated metanephrines, resulting in incorrect quantiﬁcation.
Methods: We used chemically synthesized sulfated metanephrines to establish whether the procedure most fre-quently recommended for commercial kits (pH 
1.0 for 30 min over a boiling water bath) ensures their complete hydrolysis.
Results: We found that sulfated metanephrines differ in their optimum pH to obtain complete hydrolysis. Highest yields and minimal variance were established 
for incubation at pH 0.7–0.9 during 20 min.rators; Desulfonation
rolled to ensure an efﬁcient and reproducible hydrolysis of sul-fated metanephrines. Synthetic sulfated 






























Catecholamines (norepinephrine, epinephrine and dopamine) ar
important hormones and neurotransmitters involved in cardiovascu
lar and metabolic homeostasis [1]. The physiological effects of cate
cholamines are terminated by several conjugation pathway
including 3-O-methylation followed by sulfonation at the 4-hydrox
group [1]. Norepinephrine and epinephrine are 3-O-methylated b
catechol-O-methyltransferase (COMT) into normetanephrine (NMN
(Supplementary data, 2) and metanephrine (MN) (Supplementar
data, 1), respectively [1]. Likewise, methoxytyramine (MT) (Supple
mentary data, 3) is the O-methylated form of dopamine. Sulfotrans
ferase 1A3 (SULT1A3) catalyzes the transfer of a sulfonyl grou
from the sulfate donor, 3′-phosphoadenosine-5′-phosphosulfat
(PAPS), to the free remaining hydroxy in position 4 of the phenyl rin
of metanephrines [2]. SULT1A3 is predominantly expressed in th
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uzmann).
chemie, Universität Bern, Freies-Pheochromocytoma is a neurendocrinoma that secretes excessiv
amounts of catecholamines. The diagnosis of this rare disease relie
on measures of the concentration of free metanephrines in plasm
and total metanephrines in urine and plasma [4]. Sulfated metane
phrines predominate over the unconjugated forms in human urin
[5], 87± 1%, 56±6% and 66±4% of NMN, MN and MT, respectivel
being recovered as sulfoconjugates [6]. Sulfoconjugated metane
phrines are highly hydrophilic compounds difﬁcult to directly purif
from urine by conventional solid-phase extraction protocol and lac
active groups for electrochemical detection. Acidic hydrolysis i
therefore, necessary to release the phenolic group for subsequen
electrochemical oxidation. LC MS/MS would theoretically allow direc
quantiﬁcation of sulfated metanephrines without prior hydrolysis bu
no efﬁcient solid-phase extraction method has been yet validated fo
conjugated and unconjugated metanephrines.
Total urinary metanephrines are usually measured after an aci
hydrolysis step or more rarely by enzyme treatment with aryl
sulfatase to cleave the sulfate moiety from the phenolic grou
[7–17].
Metanephrines in free form are measured by HPLC with electro
chemical or ﬂuorimetric detection, using calibrators prepared in
house by weighting free synthetic metanephrines or using certiﬁe
2calibrators provided by commercial distributors such as BioRad, 
Chromsystems or RECIPE [7–17]. It has been reported that most 
metanephrines present in calibrators and quality controls are free 
rather than sulfoconjugated forms [18]. Therefore, commercial and 
in-house calibrators based on free forms are inadequate to standard-
ize sulfated metanephrine hydrolysis because they suffer from two 
potential bias: 1) deconjugation yield cannot be assessed and
2) urine samples used as calibrators may contain small amounts of
sulfoconjugated metanephrines which upon hydrolysis will increase
the value of free, spiked metanephrines measured, resulting in an
over-estimation of the calibrator values. Even though an internal
standard is used to assess the yield of the solid-phase extraction pro-
cedure for free metanephrines, it does not guarantee full hydrolysis of
sulfated metanephrines.
The gold standard conditions for desulfonation of metanephrines, 
initially established by Pisano in 1960, consisted of acidic treatment at 
pH 0.5–0.9 for 20 min [16]. Further adaptations led to routine proce-
dures in clinical laboratories where acidic treatment at pH values 
ranging from 0.5 to 1.1 and incubation time from 20 to 45 min are 
commonly applied [7–17]. The problem is that, should shortcomings 
occur at this step (e.g., insufﬁcient acidiﬁcation), or should this step 
be omitted, the commercially available quality control samples will 
fail to alert the analyst. Assay batches will pass quality control even 
though concentrations of the clinical specimens will be severely 
underestimated, leading to false-negative results with a real potential 
for missed diagnosis of dangerous tumors.
The aim of the present work was to synthesize sulfoconjugated
metanephrines and optimize their use (Supplementary data, 4–6) as
calibrators and more importantly as quality control in the measure-
ment of fractionated urinary metanephrines.
2. Material and methods
2.1. Reagents, materials and instruments
2.1.1. Reagents and materials
All commercially available reagents and solvents (Fluka/Aldrich,
Buchs, CH) and Acros (Wohlen, CH) were used without further puri-
ﬁcation. NMN and MT were purchased from Sigma-Aldrich (St. Louis,
Mo, USA) and MN was supplied by Isosciences (King of Prussia, PA,
USA). For reactions requiring anhydrous conditions, dry solvents
were obtained by ﬁltration (Innovation Technology). In the absence
of speciﬁc instructions, the experiments were carried out under
argon atmosphere. Reactions were monitored by thin-layer chroma-
tography (Merck silica gel 60F254 plates). Detection was by UV light,
or using KMnO4 or Pancaldi reagents [(NH4)6MoO4, Ce(SO4), H2SO4,
H2O]. Puriﬁcations were performed by ﬂash chromatography on silica
gel (Merck, Zoug, CH) N° 9385 silica gel 60, 240–400 mesh and re-
verse phase HPLC.
2.1.2. Instruments
1H-NMR spectra: Bruker ARX-400, Bruker DPX-400 spectrometers
at 400 MHz and Bruker AVII-800 spectrometers at 800 MHz. Chemical
shifts in ppm relative to the solvent's residual 1H signal (MeOD:
3.34 ppm, CDCl3: 7.27 ppm, C6D6: 7.30 ppm) as internal reference.
1H assignments were conﬁrmed by 2D-COSY spectra. Multiplicity re-
ﬂects apparent patterns. Coupling constants J in Hz; b stands for
broad. 13C-NMR spectra: same instrument as above at 101 MHz. Refer-
ence for solvents used as internal reference in ppm (MeOD: 49 ppm,
CDCl3: 77 ppm, C6D6: 128.5 ppm). Coupling constants J in Hz; 13C as-
signments were conﬁrmed by 2D-HSQC spectra. IR spectra: Perkin
Elmer Paragon 1000 FT-IR spectrometer. Mass spectra: MALDI-TOF
spectrometer (Axima-CFR+, Kratos, Manchester, UK); ESI-Q spectrome-
ter (Finnigan SSQ 710 C, Thermoquest, UK); HRMS–ESI spectrometer
(Q-Tof Ultima spectrometer, Micromass, Manchester, UK). The high pu-
rity of the synthetic sulfoconjugated metanephrines (>99%) wasassessed by 1H and 13NMR spectra and HRMS–ESI analysis. Elemen-
tal analysis was not possible due to the high hygroscopicity of the
products.
2.2. Synthesis and characterization of sulfated metanephrines
The chemical protocols used for the synthesis of each sulfated
metanephrine (Supplementary data compounds 4, 5 and 6) are avail-
able in the supporting information section.
2.3. Quantiﬁcation of sulfated metanephrines
Sulfated metanephrines were quantiﬁed by two independent as-
says; 1. LC–UV quantiﬁcation: total disappearance of the sulfated
compounds upon hydrolysis (100 °C at pH 1.0 for 30 min) and con-
comitant appearance of newly formed free metanephrines were ob-
served and quantiﬁed by LC–UV using solutions of free
metanephrines prepared in house and conﬁrmed by the value
assigned with the BioRad calibrator (Reinach, Switzerland) for meta-
nephrines (see below). 2) LC–MS/MS quantiﬁcation: solutions of sul-
fated metanephrines were also directly quantiﬁed by a newly
developed LC–MS/MS method (unpublished data). The concentra-
tions found for the three sulfated metanephrines using these two in-
dependent analytical methods were highly consistent since
percentage between assigned and measured values measured by
LC–MS/MS and LC–UV, respectively, and challenged with BioRad cali-
brators were 109% and 107% for sulfated normetanephrine (S-NMN),
109% and 105% for sulfated metanephrine (S-MN) and 105% and 86%
for sulfated methoxytyramine (S-MT). Regular certiﬁed calibrator solu-
tions were BioRad Urine Standard (catalog nos. 195–5846) batch 1809
containing: NMN: 3925 nmol/l, MN: 1795 nmol/l, MT: 1878 nmol/l. In-
ternal quality controlswere a kind gift fromRECIPE (Munich, Germany)
(catalog nos. 8822). Urine calibrator and control lyophylisates were
reconstituted accordingly to the instructions of the supplier. These
two methods of quantiﬁcation enabled us to titer our stock solution
at: 3730 μmol/l for S-NMN, 400 μmol/l for S-NMN and 3800 μmol/l for
S-MT.
2.4. Validation of hydrolysis conditions
The biological matrix used included charcoal-stripped human
urine (Golden West Biologicals, Temecula, USA), urine calibrator
from Biorad, control level 1 from RECIPE, one urine spot collected
from a pool of 40 volunteers and one urine spot from one volunteer
(Vol01). Each matrix was tested for free metanephrines content be-
fore and after hydrolysis, with spiked urines containing the following
amounts of sulfated metanephrines: Spike 1: S-NMN (2800 nmol/l),
S-MN (1400 nmol/l) and S-MT (1800 nmol/l); Spike 2: S-NMN
(1400 nmol/l), S-MN (700 nmol/l) and S-MT (900 nmol/l); Spike 3:
S-NMN (700 nmol/l), S-MN (350 nmol/l) and S-MT (450 nmol/l).
Free metanephrines were measured as indicated by the protocol pro-
vided by RECIPE. Spiked amount of S-MNs was chosen to mimick nor-
mal and pathological concentrations found during routine
measurements. The initial pH of urine (charcoal stripped human
urine, Biorad calibrator, RECIPE internal quality controls and urine
pool) was adjusted at pH 1.0 and stored at−20 °C. The internal stan-
dard 3-methoxy-4-hydroxybenzylamine (MHBA) was added prior to
hydrolysis and pH-adjusted with HCl or NaOH to reach a given pH
that ranged from 0.5 to 7.0 (see below). Hydrolysis was carried out
over a boiling bath (100 °C) during a period ranging from 1 to
60 min (see below). Free metanephrines were then measured using
the RECIPE metanephrines extraction kit (RECIPE, catalog nos.
4000). Forty microliters of eluate was injected into an isocratic HPLC
model equipped with a dual piston pump and an autoinjector
(model 542) coupled to a 5600A electrochemical Coularray system






































































































3gasket was set to 30 °C and ﬂow rate adjusted to 1 ml min−1. Th edetec-
tion was done with one cell module containing four electrochemical de
tector cells with cell potentials maintained at 240, 320, 340 and 36
mV, beginning with the ﬁrst serially aligned sensor [4]. The inter-assa
quality control was assessed by C1 value determination from RECIPE
coefﬁcient of variation was 2.0% for normetanephrine (1400 nmol/l), 4.0
for metanephrine (715 nmol/l) and 4.0% for methoxytyramine (90
nmol/l).
2.4.1. pH range and hydrolysis yields
Charcoal stripped urine and native urine samples (Vol01) wer
both supplemented with spike 2 and heated (100 °C for 30 min) a
various pH (0.5, 1.0, 1.5, 2.0 and 3.0). Free metanephrine concentra
tions obtained after hydrolysis, were compared with those produce
by hydrolysis at pH 1.0 for 30 min (gold standard, considered a
quantitative hydrolysis). Controls consisted of Biorad calibrator an
unspiked native urine.
2.4.2. Time range and hydrolysis yield
Incubation times (0, 1 min, 5 min, 10 min, 20 min, 30 min an
60 min) were chosen for the hydrolysis of sulfated metanephrine
in a native urine pool collected from several volunteers and supple
mented with spike 2. The experiments were performed at pH 1.0 t
meet the recommended procedures.
2.4.3. Simultaneous effect of pH and duration on the rate of hydrolysis
Samples of the urine pool were adjusted to ﬁve pH values by 0.
unit increments starting from pH 0.5 up to 1.5. For each pH value, hy
drolysis was performed for 20, 25, 30 and 35 min at 100 °C. Half of th
samples were spiked with sulfated metanephrines (spike 2). A total o
456 measurements were performed within 23 experiments durin
3 months by two experienced technicians to take day-to-day variabilit
into account.
2.5. Statistical analyses
In order to compare the mean concentrations of NMN, MN and M
obtained under different conditions (calibrator, calibrator and addi
tion of exogenous synthetic sulfated metanephrines at three level
of concentration), non-parametric tests (Kruskal–Wallis equality-of
populations rank test) were run for each metanephrine. For signif
icant differences, Mann–Whitney post tests were also carried ou
to compare calibrator means after each addition of exogenous syn
thetic sulfated metanephrines and Bonferroni corrections wer
used to take multiple testing into account (alpha of 1.667% instea
of 5%).
To evaluate the optimal conditions for hydrolysis of sulfated meta
nephrines (greatest mean concentration and the lowest variability o
measurements), linear multiple regressions were calculated for MN
NMN and MT with time (20, 25, 30 and 35 min taking 30 min as ref
erence group) and pH (0.5–0.7, 0.7–0.9, 0.9–1.1, 1.1–1.3 and 1.3–1.
with the interval of 0.9–1.1 as reference group) as covariables
These models were adjusted for spike effects by introducing a spik
factor (spike vs no spike, no spike as reference group) and its interac
tion with pH. The outcome was the amount of sulfated metane
phrines in urine. Therefore for the spiked urines, this quantity wa
deﬁned as the total sulfatedmetanephrines foundminus the theoretica
spike added to the urine. As therewas a spike effect (main effect of spik
with an underestimation of the threemetanephrines and an interaction
between spike and pH for the S-NMN and the S-MN), the spiked an
unspiked urines were analyzed separately. Second, Levene's tests of ho
mogeneity of variance were run to evaluate the optimal conditions t
minimize variability around each mean. Desulfonation was assume
to have taken place from the point in time when only values below
the conﬁdence limits were observed. Desulfonation was considere
relevant when it exceeded 10%.3. Results
3.1. Synthesis of sulfated metanephrines
While Hegedus reported the preparation of sulfoconjugates 5 an
6 using chlorosulfonic acid and pyridine, a general protocol for the ef
ﬁcient and selective sulfoconjugation of metanephrines and analog
was not available [19]. Starting from free metanephrines, we aimed a
sulfonation of the phenol moieties under mild conditions. To this en
adequate protection of the other reactive functions was required. 3
Methoxytyramine (3) was transformed into the corresponding ter
butyl carbamate in almost quantitative yield (Supplementary data).
All attempts to obtain direct sulfonation of the phenolic grou
with SO3-amine complexes [20–24] were unsuccessful leading to de
composition of the starting material or to complex mixtures. An alter
native strategy based on the use of the protected sulfonation reagen
8 [25,26] was investigated [27,28]. Following the procedure of Taylo
[29], treatment of phenol 7 (0.3 M concentration in the reaction me
dium) with an excess of 8 in the presence of triethylamine and DMA
afforded the sulfate diester 10 in 94% yield. Removal of the carbamat
moiety by triﬂuoroacetic acid in water led to a concomitant complet
desulfonation with recovery of the starting 3-methoxytyramine (3)
Gratifyingly, a sequence of hydrogenolysis catalyzed by Pd/C usin
ammonium formate as source of hydrogen [30], followed by cleavag
of the tert-butyl carbamate in the presence of 5% triﬂuoroacetic aci
in dichloromethane, provided the desired aryl sulfate 6 in 95% yiel
(2 steps).
The sulfonation of normetanephrine and metanephrine followed 
similar approach (Supplementary data). After protection of th
amines as the tert-butyl carbamates 11 and 18 in high yield, a ﬁrst at
tempt of sulfonation of 11 with reagent 8 resulted in a low conversio
toward a mixture of the desired sulfate diester 12 (11% yield) and th
product of sulfonation on the side-chain hydroxyl group (13, 17%
yield). Intermediates 11 and 18 were thus converted into the bis-tert
butyldimethylsilyl ethers. According to the methodology develope
by Jiang et al. [30], the phenol moiety was selectively deprotected i
the presence of cesium carbonate to afford phenols 15 and 19 in hig
yields. Further sulfonation with excess of 8 delivered the expecte
diesters 19 and 20 in 88 and 75% yield, respectively. After ﬂuoride
promoted re-moval of the silyl protecting group, hydrogenolysis i
the presence of Pd/C and ammonium formate was not met wit
success. Removal of the trichloroethyl group was thus carried ou
with zinc and ammonium formate [29]. Final cleavage of th
carbamate moieties delivered the sul-foconjugated normetanephrin
5 and sulfoconjugated metanephrine 4 in good yield.
The use of chlorosulfuric acid 2,2,2-trichloroethyl ester provide
an efﬁcient alternative for the sulfonation of metanephrines and ana
logs which could not be achieved with classical methodologies usin
SO3-amine complexes. With the protocols disclosed herein, sulfocon
jugate 6was obtained in 4 steps and 79% overall yield from the paren
3-methoxytyramine while sulfoconjugated normetanephrine an
metanephrine were delivered in 7 steps with 35 and 25% overa
yields respectively.
3.2. Sulfated metanephrines in urine calibrator and control
The Biorad calibrator and the control level 1 (C1) from RECIP
contain low amounts of sulfated metanephrines (b2% for S-NMN
b7% for S-MN; b6% for S-MT) since the concentration of metane
phrines is not signiﬁcantly different before and after hydrolysis fo
calibrator and C1 without spikes (A vs B and C vs D, respectively, Sup
plementary data). The addition of exogenous synthetic sulfated meta
nephrines at three concentration levels of concentration in th
calibrator and C1, while it was not detected in unhydrolyzed urine
is clearly measured after hydrolysis (ratio of found versus expecte
4concentrations ranging from 95.8 to 106.9% for S-NMN, 92.8 to 100.9%
for S-MN and 100.3 to 108.2% for S-MT, B and D, Supplementary
data).3.3. Behavior of synthetic and endogenous sulfated metanephrines toward
hydrolysis under different pH
Optimal hydrolysis was observed when samples were adjusted at
pH 1.0 prior to heating at 100 °C for 30 min. Increasing the pH led to a
dramatic decrease of hydrolysis yield since at pH 2.0 only 25% of S-
NMN, 45% of S-MN and 18% of S-MT were hydrolyzed. No hydrolysis
was observed for pH values above 2.0. Besides, heating at 100 °C is a
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Fig. 1. Quantiﬁcation of NMN (A), MN (B) and MT (C) in charcoal-stripped urine com-
plemented with S-MNs from spike 2, urine from one volunteer (Vol01) with S-MNs
from spike 2 and the same urine not complemented with S-MNs. Samples were adjust-
ed to pH values ranging from 0.5 to 3.0 and heated. Values were expressed in %, com-
pared to values obtained for corresponding samples at pH 1.0 (pH of reference
according to the guidelines). Biorad Calibrator was used as control.30 min at 20 °C did not affect the stability of sulfated metanephrines
(data not shown).
Since the optimal pH range for hydrolysis appeared narrow, we 
evaluated whether the hydrolysis of synthetic and endogenous sulfated 
metanephrines was similar between pH 0.5 and 3.0. We observed that 
hydrolysis yields for the three sulfated metanephrines were similar in 
the spiked charcoal stripped urine (spike 2), the native urine and 
the spiked native urine (Fig. 1A for S-NMN, B for S-MN, C for S-MT). 
Howev-er, considering hydrolysis conditions at pH 1.0 for 30 min as 
the gold standard, it appears that pH tolerance around this target 
is limited since hydrolysis of sulfated metanephrines was already 
reduced by approx. 20% at pH 0.5 and 1.5.
3.4. Effect of incubation time on hydrolysis yield
Hydrolysis of the three sulfated metanephrines at 100 °C started 
after 1 min of incubation to reach 60% of desulfonation after 5 min. 
A plateau was reached between 20 AND 30 min for both native 
(Fig. 2A) and spiked (Fig. 2B) urines.
3.5. Simultaneous effects of pH and duration on hydrolysis yields
We conducted similar experiments as those described above (in-
cubation time) using a much larger set of samples (456 samples in
23 experiments during 3 months) in order to test reproducibility
and increase the accuracy of the results including pH variability with-
in short intervals (0.5 to 1.5). We found no signiﬁcant time effect

















0 1 5 10 20 30 60
%
Time [min]







Fig. 2. (A) Quantiﬁcation of NMN, MN and MT in pooled urine from 40 volunteers ad-
justed to pH 1.0 prior to incubation at 100 °C at various time points (1 to 60 min).
Values were expressed in %, compared to values obtained for corresponding samples
incubated for 30 min (time of reference according to the guidelines). (B) The urine






















































Simultaneous effects of pH and duration on the percentage of hydrolysis of sulfated metanephrines for unspiked urines.
NMN MN MT
Beta Conﬁdence interval at 95% p-Value Beta Conﬁdence interval at 95% p-Value Beta Conﬁdence interval at 95% p-Value
Time reference: 30 min
20 min −17.67 [−61.08; 25.73] 0.423 −5.41 [−25.01; 14.2] 0.587 −59.95 [−196.59; 76.69] 0.388
25 min −7.36 [−50.28; 35.55] 0.736 0.34 [−19.05; 19.72] 0.973 −31.78 [−166.88; 103.33] 0.643
35 min 5.04 [−37.71; 47.78] 0.817 4.24 [−15.07; 23.54] 0.666 21.32 [−113.24; 155.88] 0.755
pH reference: [0.9–1.1]
[0.5–0.7] −60.20 [−107.84; −12.56] 0.014 −50.95 [−72.47; −29.43] 0.000 −62.36 [−212.34; 87.62] 0.413
[0.7–0.9] 35.03 [−6.17; 76.24] 0.095 −2.69 [−21.3; 15.92] 0.776 170.57 [40.86; 300.28] 0.010
[1.1–1.3] 7.70 [−39.93; 55.32] 0.750 10.58 [−10.93; 32.09] 0.333 −46.78 [−196.71; 103.15] 0.539
[1.3–1.5] −15.70 [−71.41; 40.01] 0.579 12.16 [−13; 37.33] 0.342 −121.65 [−297.02; 53.72] 0.173
Intercept 590.55 [550.21; 630.89] 0.000 259.96 [241.74; 278.18] 0.000 1447.01 [1320.02; 1574.01] 0.000
5sulfated metanephrines, during hydrolysis of native or spike
urines indicating that 20 min is sufﬁcient for hydrolysis comple-tio
(Tables 1 and 2). We also found an underestimation of the thre
metanephrines and an interaction between spike and pH fo
normetanephrine and metanephrine (Tables 1, 2 and 3
Therefore, the spiked and unspiked (native) urines were analyze
separately.
3.5.1. Native urines
Multiple linear regression analyses were carried out for nativ
urines hydrolyzed at pH 0.9–1.1 for 30 min; these yielde
585 nmol/l free normetanephrine and signiﬁcantly 60 nmol/l less a
pH 0.5–0.7 (p= 0.014) but marginally signiﬁcantly 35 nmol/l mor
at pH 0.7–0.9 (p= 0.095). S-MN at a concentration of 50 nmol/l wa
signiﬁcantly less hydrolyzed at pH 0.5–0.7 than in the pH interval o
0.7–1.5 (209 vs 259 nmol/l, p b 0.001). The best yield for the hydroly
sis of S-MT was observed at pH 0.7–0.9 compared to pH 0.9–1.1 (159
vs 1430 nmol/l, p b 0.01) (Table 1).The variances of the mean
showed that compared to pH 0.9–1.1, the lowest variability of hydro
lysis for the highest mean concentration was observed for S-NMN a
pH 0.7–0.9 (108 vs 150 nmol/l, p= 0.009), for S-MN at pH 0.7–1.
(40 vs 69 nmol/l, p= 0.001) and for S-MT at pH 0.7–0.9 (357 v
460 nmol/l, p= 0.037) (Table 3).
3.5.2. Spiked urines
The best hydrolysis yields and lowest variances were observed be
tween pH 0.7–1.3 for exogeneous S-NMN, at pH 1.1–1.3 for S-MN an
at pH 0.7–0.9 for S-MT (Tables 2 and 3).
4. Discussion
Our study conﬁrmed that most metanephrines in urine control
and calibrators represent free rather than sulfoconjugates, a
previously reported [18]. Therefore, commercial and in-hous
calibrators based on
Table 2
Simultaneous effects of pH and duration on the percentage of hydrolysis of sulfated met
NMN MN
Beta Conﬁdence interval at 95% p-Value Beta
Time reference: 30 min
20 min −16.59 [−73.41; 40.24] 0.566 −9.70
25 min −29.40 [−86.99; 28.19] 0.315 −5.46
5 min 15.30 [−42.08; 72.68] 0.600 3.86
pH reference: [0.9–1.1]
[0.5–0.7] −147.75 [−207.93; −87.56] 0.000 −144.06
[0.7–0.9] −11.52 [−66.81; 43.77] 0.682 −53.67
[1.1–1.3] 29.76 [−29.03; 88.56] 0.319 50.29
[1.3–1.5] −157.26 [−237.27; −77.25] 0.000 20.79
Intercept 448.87 [398.59; 499.16] 0.000 154.35free forms are inadequate for standardization of sulfated metanephrin
hydrolysis and should be replaced by “true calibrators” that correctl
mimic endogenous metabolites as they complete sample preparation
prior to analytical quantiﬁcation.
We found that in the investigated time frame, 20 min is sufﬁcien
to achieve a complete hydrolysis of sulfated metanephrines withou
degradation of free metanephrines. For native urines, a pH betwee
0.7 and 0.9 seems optimal for all metanephrines whereas below o
above this pH interval the hydrolysis yields decrease rapidly an
interassay variability increases. The advantage of standardized condi
tions for hydrolysis is a narrowing of the reference intervals between
all laboratories for sulfated metanephrines in a given population
Therefore, external quality assessment for urinary metanephrin
monitoring should reﬂect the sole analytical variability caused by in
strumental set-up with no consideration for sample preparation
Another improvement for proﬁciency testing would also be expected
by using a synthetic source of sulfated metanephrines as calibrators. In
deed, the synthetic and endogenous S-NMN and S-MT exhibit simila
behavior with an optimal pH hydrolysis between 0.7 and 0.9. A sligh
difference is observed for S-MN where the relatively large toleranc
for pH conditions in native urines (pH 0.7–1.5) is restricted to pH 1.1
1.3 with synthetic compounds. This discrepancy is likely due to the rela-
tively low concentration of sulfate metanephrine in natural urine com
pared with the high concentration in the spiked samples (270 v
700 nmol/l), a difference which increases the variance of th
assay (Tables 2 and 3).
In conclusion, the efﬁcient and selective chemical protocols devel
oped for the synthesis of sulfated metanephrines represent an impor
tant progress which overcomes entrenched major shortcomings in
the monitoring and diagnosis of catecholamine-producing tumors
Moreover, these chemically pure compounds represent a source o
calibrators and quality controls to build an effective testing neede
to provide accuracy between all laboratories involved in the biochem
ical diagnosis of pheochromocytoma.anephrines for spiked urines.
MT
Conﬁdence interval at 95% p-Value Beta Conﬁdence interval at 95% p-Value
[−42.56; 23.16] 0.561 −78.67 [−236.75; 79.41] 0.328
[−38.76; 27.84] 0.747 −55.90 [−216.1; 104.31] 0.492
[−29.32; 37.04] 0.819 13.88 [−145.75; 173.5] 0.864
[−178.86; −109.26] 0.000 −44.90 [−212.33; 122.54] 0.598
[−85.64; −21.7] 0.001 195.15 [41.34; 348.96] 0.013
[16.29; 84.29] 0.004 −65.64 [−229.21; 97.92] 0.430
[−25.48; 67.05] 0.377 −330.65 [−553.24; −108.07] 0.004
[125.27; 183.43] 0.000 1637.23 [1497.33; 1777.13] 0.000
Table 3
Signiﬁcance of mean differences from multiple regression analyses with pH as factors.
NMN MN MT
pH Natural urines p-Value Spiked urines p-Value Natural urines p-Value Spiked urines p-Value Natural urines p-Value Spiked urines p-Value
[0.5–0.7] Mean 525.91 0.014 293.49 b0.001 209.08 b0.001 7.57 b0.001 1368.86 0.413 1562.65 0.598
sd 86.35 b0.001 128.01 0.813 32.34 b0.001 52.60 0.009 286.44 0.001 383.40 0.030
[0.7–0.9] Mean 620.51 0.095 429.46 0.682 257.00 0.776 97.53 0.001 1599.65 0.010 1799.63 0.013
sd 108.39 0.009 157.64 0.335 48.11 0.008 95.74 0.204 357.40 0.037 386.06 0.278
[0.9–1.1] Mean 585.69 Ref 441.45 Ref 259.82 Ref 151.62 Ref 1430.06 Ref 1608.03 Ref
sd 150.91 Ref 137.86 Ref 69.58 Ref 79.27 Ref 460.17 Ref 465.81 Ref
[1.1–1.3] Mean 592.91 0.750 471.53 0.319 270.20 0.333 201.98 0.004 1381.49 0.539 1542.49 0.430
sd 86.24 b0.001 137.16 0.990 40.44 0.001 88.12 0.894 258.53 b0.001 354.15 0.027
[1.3–1.5] Mean 571.18 0.579 282.52 b0.001 272.38 0.342 171.68 0.377 1312.21 0.173 1272.74 0.004
sd 93.75 0.016 209.95 0.116 45.85 0.026 118.48 0.163 298.48 0.029 452.16 0.901
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